Update on emerging urate-lowering therapies (vol 21, pg 143, 2009)

被引：0
|
作者：
Chohan, S.
Becker, M. A.
机构：
来源：
CURRENT OPINION IN RHEUMATOLOGY | 2010年 / 22卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Oughts and ends (vol 143, pg 315, 2009)
    Finlay, Stephen
    PHILOSOPHICAL STUDIES, 2022, 179 (07) : 2415 - 2415
  • [32] New urate-lowering therapies in Aotearoa New Zealand: a response to Dr Lance Gravatt's letter on benzbromarone hepatotoxicity
    Dalbeth, Nicola
    Gow, Peter
    Stamp, Lisa
    Merriman, Tony
    Stuart, Raoul
    Winnard, Doone
    Lindsay, Karen
    NEW ZEALAND MEDICAL JOURNAL, 2013, 126 (1382) : 120 - 123
  • [33] INDIRECT COMPARISON OF URATE-LOWERING THERAPIES FOR HYPERURICEMIC PATIENTS WITH OR WITHOUT GOUT: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Fan, M.
    Liu, J.
    Zhao, B.
    Wu, X.
    Gu, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1183 - 1184
  • [34] Comparison of efficacy and safety of urate-lowering therapies for hyperuricemic patients with gout: a meta-analysis of randomized, controlled trials
    Fan, Meida
    Liu, Jian
    Zhao, Bingcheng
    Wu, Xinyu
    Li, Xuefeng
    Gu, Jieruo
    Schlesinger, Naomi
    CLINICAL RHEUMATOLOGY, 2021, 40 (02) : 683 - 692
  • [35] Comparison of efficacy and safety of urate-lowering therapies for hyperuricemic patients with gout: a meta-analysis of randomized, controlled trials
    Meida Fan
    Jian Liu
    Bingcheng Zhao
    Xinyu Wu
    Xuefeng Li
    Jieruo Gu
    Naomi Schlesinger
    Clinical Rheumatology, 2021, 40 : 683 - 692
  • [36] OIE update on wildlife diseases (vol 143, pg 31, 1998)
    不详
    VETERINARY RECORD, 1998, 143 (05) : 120 - 120
  • [37] Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis
    Zhao Li
    Cao Ling
    Zhao Tian-Yi
    Yang Xue
    Zhu Xiao-Xia
    Zou He-Jian
    Wan Wei-Guo
    Xue Yu
    中华医学杂志(英文版), 2020, 133 (08) : 982 - 993
  • [38] Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis
    Zhao, Li
    Cao, Ling
    Zhao, Tian-Yi
    Yang, Xue
    Zhu, Xiao-Xia
    Zou, He-Jian
    Wan, Wei-Guo
    Xue, Yu
    CHINESE MEDICAL JOURNAL, 2020, 133 (08) : 982 - 993
  • [39] Emerging Therapies (vol 32, pg 347, 2018)
    Guerra, A.
    Musallam, K. M.
    Taher, A. T.
    Rivella, S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (03) : XIII - XIII
  • [40] Primary immunodeficiencies: 2009 update (vol 124, pg 1161, 2009)
    Notarangelo, L. D.
    Fischer, A.
    Geha, R. S.
    Casanova, J. L.
    Chapel, H.
    Conley, M. E.
    Cunningham-Rundles, C.
    Etzioni, A.
    Hammartrom, L.
    Nonoyama, S.
    Ochs, H. D.
    Puck, J.
    Roifman, C.
    Seger, R.
    Wedgwood, J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (03) : 771 - 773
12345